Publication date | Communities | Collections | Article title | Author(s) | Journal/Conference |
---|---|---|---|---|---|
1 Jan 2014 | BMRC | Institute of Molecular and Cell Biology | Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations | Angie Hui Ling Yeo, Tse Siang Kang, Boon Tin Chua, Han Kiat Ho | Drug Discovery Today |